Walter Reed Army Institute of Research and the Race for a Zika Vaccine
When the Zika virus emerged as a global threat, the Walter Reed Army Institute of Research (WRAIR) drew on its ...
Tag: WRAIR
DoD Awards 14M Japanese Encephalitis Vaccine Contract
The Defense Logistics Agency Distribution has awarded a notable medical countermeasure contract to Intercell USA Inc. of Gaithersburg, Maryland. Intercell ...
1st AML Hosts Operational Clinical Infectious Disease Course
The 1st Area Medical Laboratory (1st AML) recently hosted a three-day course in Operational Clinical Infectious Disease (OCID). As the ...
Military Recruiting Volunteers for Human Trials of Malaria Vaccines
After extensive research and development efforts, the Naval Medical Research Center (NMRC) team at the NMRC Clinical Trials Center (CTC), ...
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program
PaxVax last week announced a partnership with the National Institutes of Health (NIH) and United States Department of Defense (DoD) on its ...
The U.S. Military Contribution to Global Fight to End AIDS
Rick Shaffer, Ph.D., director of the DoD HIV/AIDS Prevention Program (DHAPP) at the Naval Health Research Center. Credit: Regena Kowitz, ...
Biosecurity Research Institute: Zika Virus Infection May Prevent Reinfection
Kansas State University's Biosecurity Research Institute. Credit: K-State News People infected with Zika virus may not be susceptible to Zika ...
Army’s Mobile Laboratory Unit Certifies for Global Mission
Members from the 1st AML go over the proper steps for sample collection. The only deployable laboratory in the Army, ...
DTRA-Backed Ebola Vaccine Moves Closer to Being Licensed
The unprecedented Ebola epidemic in West Africa first broke out in Guinea in March 2014, and quickly spread to neighboring ...
WRAIR Contract with Remel Inc. Supports Surveillance of Drug-Resistant Organisms
The United States Army Medical Research Acquisition Activity has announced intentions to award a sole source contract to Remel Inc., ...
NIH: Vaccines Protect Monkeys Against Zika Infection
The National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) is supporting research and development of ...
First-In-Human Study of MERS Vaccine Completes Enrollment
A Phase I clinical trial for Middle East Respiratory Syndrome GLS-5300 vaccine, funded and conducted by the Walter Reed Army ...
Human Trial of Zika Vaccine Begins
At least 80 healthy volunteers ages 18-35 years at three study sites in the United States are expected to participate ...
Mapping Zika’s Routes to Support Countermeasure Development
Zika virus infects numerous primary cell types and explants of the human placenta, suggesting placental and paraplacental routes of virus ...
USAMRD-G Awarding Follow-On Security Contract at Lugar Center
The US Army Medical Research Directorate-Georgia (USAMRD-G) is establishing a new security contract with the National Center of Disease Control ...
U.S. Army Partners with Sanofi Pasteur to Develop Zika Vaccine
The U.S. Army’s Walter Reed Army Institute of Research (WRAIR) and Sanofi Pasteur this week announced a collaborative agreement for ...
Zika Snapshot: Virus Clone, Rapid Response Grants, DoD Biosurveillance
The Global Biodefense Zika Snapshot is a quick update on the latest news and research related to the Zika virus ...
Walter Reed Kicks Off Phase 1 MERS Vaccine Trial
A Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East ...
Inovio and GeneOne Kick Off MERS Vaccine Trial
Inovio Pharmaceuticals, Inc. recently announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle East Respiratory Syndrome). ...
Rapid Screening Method to Identify Ebola Drugs
Credit: Shutterstock Researchers have demonstrated the use of a mini-genome system as a quick screening method to evaluate candidate drugs ...
